[1]樊孝廉,鲁胜男,古炎发,等.乳腺癌患者骨病灶SPECT/CT融合显像的临床价值[J].国际放射医学核医学杂志,2013,37(4):221-224.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
　FAN Xiao-lian,LU Sheng-nan,GU Yan-fa,et al.The clinical value of SPECT/CT fusion imaging in the diagnosis of bone metastasis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):221-224.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
点击复制

乳腺癌患者骨病灶SPECT/CT融合显像的临床价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
37
期数:
2013年第4期
页码:
221-224
栏目:
论著
出版日期:
2013-07-25

文章信息/Info

Title:
The clinical value of SPECT/CT fusion imaging in the diagnosis of bone metastasis of breast cancer
作者:
樊孝廉;  鲁胜男;  古炎发;  张爱芳
528200 佛山, 南方医科大学附属南海医院, 佛山市南海区人民医院核医学科
Author(s):
FAN Xiao-lian;  LU Sheng-nan;  GU Yan-fa;  ZHANG Ai-fang
Department of Nuclear Medicine, the Affiliated Nanhai Hospital of Southern Medical University, People’s Hospital of Nanhai District, Foshan 528200, China
关键词:
乳腺肿瘤; 肿瘤转移; 体层摄影术; 发射型计算机; 单光子; 体层摄影术; X线计算机
Keywords:
Breast neoplasms; Neoplasms metastasis; Tomography; emission-computed; singlephoton; Tomography; X-ray computed
DOI:
10.3760/cma.j.issn.1673-4114.2013.04.008
摘要:
目的 探讨SPECT/CT融合显像诊断与鉴别乳腺癌患者全身骨显像放射性异常浓聚灶的临床价值。方法 对25例乳腺癌患者的99Tcm-MDP全身骨显像显示的骨异常放射性浓聚灶行SPECT/CT融合显像。4~8个月后再次行全身骨显像及SPECT/CT融合显像复查。图像由两名有经验的核医学科医师独立分析,部分CT图像由有经验的放射科医师分析指导。结果 在25例乳腺癌患者的37个异常放射性浓聚灶中,确定29 (29/37,78.38%)个病灶为骨转移灶,其中有2个椎体病灶在初次检查中判读为良性病灶;8(8/37,21.62%)个病灶为良性病灶,其中1个肋骨病灶在初次检查中判读为骨转移灶,比较全身骨显像和SPECT/CT融合显像,二者之间差异有统计学意义(χ2=6.975,P<0.05)。骨转移灶主要分布于椎骨及肋骨。全身骨显像和SPECT/CT融合显像的诊断灵敏度、特异度、阳性预测值、阴性预测值和准确率分别为82.76%、75.00%、92.31%、54.55%、81.08%和93.10%、87.50%、96.43%、77.78%、91.89%。采用受试者操作特性曲线(ROC)进行分析,结果:全身骨显像曲线下面积为0.860±0.056,SPECT/CT融合显像曲线下面积为0.974±0.020.SPECT/CT融合显像曲线下面积大于全身骨显像曲线下面积,两者之间差异具有统计学意义(χ2=9.924,P<0.001)。结论 SPECT/CT融合显像较全身骨显像能更好地鉴别出乳腺癌骨病灶的性质,能够提高诊断准确率,具有重要的临床价值;必要时应在4~8个月后复查SPECT/CT。
Abstract:
Objective To evaluate the clinical value of SPECT/CT fusion imaging in the diagnosis and differential diagnosis the characteristic of the whole body bone scan radioactive hot lesions in patients with breast cancer.Methods The abnormal radioactive hot lesions of whole body bone scan in 25 patients with breast cancer underwent SPECT/CT fusion imaging immediately.Another whole body bone scan and SPECT/CT fusion imaging were carried out 4 to 8 months later in all these patients.The whole body bone scan images,SPECT/CT images and fusion images were analyzed independently by two experienced nuclear medicine physicians and some of the equivocal CT images were analyzed by an experienced radiologist.Results Among all the 37 abnormal radioactive hot bone lesions,29 (29/37,78.38%) lesions were confirmed metastatic lesions,including 2 vertebral lesions classified as benign lesions on the basis of the first examinations data; and 8 lesions were benign,including a rib lesion classified as benign lesion according to the first examinations data.The difference between whole body bone scan and SPECT/CT examination was statistically significant (χ2=6.975,P<0.05).The bone metastases are located mainly in spine and ribs.The sensitivity,specificity,positive and negative predictive values,and accuracy of whole-body bone scan and SPECT/CT fusion imaging were 82.76%,75.00%,92.31%,54.55%,81.08% and 93.10%,87.50%,96.43%,77.78%,91.89%,respectively.The area under the receiver operating characteristics curve was 0.860±0.056for whole body bone scan and 0.974±0.020 for SPECT/CT.The area under the curve for SPECT/CT was significantly larger compared with the whole body bone scan (χ2=9.924,P<0.001).Conclusions SPECT/CT fusion imaging is better than whole body bone scan alone to characterize the abnormal bone radioactive hot lesions and it can improve the accuracy of diagnosis.The patients should repeat the modality 4 to 8 months later if necessary.

参考文献/References:

[1] Jemal A, Siegel K, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57(1):43-66.
[2] 周涛,陈丽芬. 30岁以下乳腺癌临床病理特征及分子生物学特点分析. 国际肿瘤学杂志,2006,33(11):874-877.
[3] 汤志谋,许海富,李明智. SPECT核素骨显像联合MRI增强成像鉴别诊断骨转移瘤100例临床观察. 实用癌症杂志,2009,24(5):498-500.
[4] 韩鹏慧,张书旭,葛永兵,等. SPECT/螺旋C T融合显像鉴别诊断颅骨良恶性病变的临床价值. 中国临床医学影像杂志,2012,23(7):484-487.
[5] 李少林,王荣福. 核医学. 7版. 北京:人民卫生出版社,2008:153.
[6] Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med, 2005, 46(8):1356-1367.
[7] Horger M, Bares R. The role of single photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med, 2006, 36(4):286-294.
[8] Sharma P, Singh H, Kumar R, et al. Bone scintigraphy in breast cancer:added value of hybrid SPECT-CT and its impact on patient management. Nucl Med Commun, 2012, 33(2):139-147.

相似文献/References:

[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
　Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
　Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
　chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
　Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[5]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
　Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[6]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
　Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[7]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
　Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[8]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
　Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[9]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
　Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[10]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
　Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[11]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
　Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[12]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
　Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[13]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
　YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[14]路宝士,高玉芳.血清CA15-3、CEA检测联合全身骨显像在乳腺癌骨转移中的诊断价值[J].国际放射医学核医学杂志,2011,35(2):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
　LU Bao-shi,GAO Yu-fang.The value of combined examination of serum CA15-3, CEA level and whole body bone scan in the diagnosis of bone metastasis in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
[15]佟丽娟,王明泽,王丽梅.肺癌、乳腺癌、食道癌远端骨转移特点的对比研究[J].国际放射医学核医学杂志,2011,35(1):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
　TONG Li-juan,WANG Ming-ze,WANG Li-mei.Comparative study between characteristics of the lung cancer, breast cancer and esophageal cancer distal bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
[16]袁超,陶健,袁媛,等.血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2009,33(6):353.[doi:10.3760/cma.j.issn.1673-4114.2009.06.011]
　YUAN Chao,TAO Jian,YUAN Yuan,et al.The diagnostic significance of CA15-3, CEA combined with whole body bone scan for bone metastases in patients with breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):353.[doi:10.3760/cma.j.issn.1673-4114.2009.06.011]
[17]张亶,章斌,邓胜明,等.18F-FDG PET/CT在乳腺癌术后随访中的价值[J].国际放射医学核医学杂志,2017,41(3):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]
　Zhang Dan,Zhang Bin,Deng Shengming,et al.Clinical value of 18F-FDG PET/CT in follow-up of postoperative breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]
[18]张雪辉,杨贵生,肖国有.乳腺癌骨转移的影像学诊断进展[J].国际放射医学核医学杂志,2017,41(4):278.[doi:10.3760/cma.j.issn.1673-4114.2017.04.008]
　Zhang Xuehui,Yang Guisheng,Xiao Guoyou.Imaging for diagnosis of bone metastases in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):278.[doi:10.3760/cma.j.issn.1673-4114.2017.04.008]

备注/Memo

备注/Memo:
收稿日期:2013-03-26。
通讯作者:樊孝廉,Email:FANXL2@163.com
更新日期/Last Update: 1900-01-01